1. Home
  2. Research
  3. Research Groups
  4. Drug utilisation and health outcomes of pharmacotherapy

Drug utilisation and health outcomes of pharmacotherapy

We are a transversal group, we have a wide knowledge and training in relation to pharmacotherapy with a high complexity and specialization. We are experts in the safe and effective use of medicines, applying efficiency and innovation criteria. On the other hand, being a central service, we have experience in process management.

Our clinical areas with greater presence of pharmacists are: elderly patient (geriatrics), infectious (HIV, HCV, HBV, HBV, PROA), hematology, rheumatology, dermatology, neurology and emergency. We offer:

  • Pharmacovigilance, medication safety experience.
  • Knowledge and availability of medications.
  • Data on the use and consumption of medicines.
  • Preparation of drug preparations.
  • Clean rooms.
  • Drug-related technologies.
  • Structure for the management and development of Clinical Trials.
  • Quality Management System Certification.

Search for publications

Only original articles, editorials, guidelines.

  • Sheikh J, Allotey J, Sobhy S, Plana MN, Martinez-Barros H, Naidu H, Junaid F, Sofat R, Mol BW, Kenny LC, Gladstone M, Teede H, Zamora J, Thangaratinam S.

    Maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit/hyperactivity disorder in offspring: umbrella review of systematic reviews.

    BMJ-BRITISH MEDICAL JOURNAL . 391: .

    [doi:10.1136/bmj-2025-088141]

  • Álvarez-Díaz AM, Crespo Diz C, Monte Boquet E, Marcos Rodríguez JA, Margusino Framinan L, Sánchez Yañez E, Vélez-Díaz-Pallarés M, Vicente Escrig E, Morillo-Verdugo R.

    [Translated article] Qualitative study on the adoption and enhancement of the capacity-motivation-opportunity model for pharmaceutical care in outpatient pharmacy consultations in Spain.

    FARMACIA HOSPITALARIA . 49(6): .

    [doi:10.1016/j.farma.2025.05.002]

  • Álvarez Díaz AM, Crespo Diz C, Monte Boquet E, Marcos Rodríguez JA, Margusino Framinan L, Sánchez Yañez E, Vélez-Díaz-Pallarés M, Vicente Escrig E, Morillo-Verdugo R.

    Qualitative study on the adoption and enhancement of the capacity-motivation-opportunity model for pharmaceutical care in outpatient pharmacy consultations in Spain.

    FARMACIA HOSPITALARIA . 49(6): 384-391.

    [doi:10.1016/j.farma.2025.03.003]

  • Rodriguez-Tierno S, Sáez de la Fuente J, Fuertes Pina L, Escudero-Sánchez R, Ruiz-Garbajosa P, Guijarro Martínez P, Gioia F, Pintor Recuenco MDR, Álvarez-Díaz A.

    Real-life experience with use of cefiderocol in non-critically ill patients in a tertiary care hospital.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . 43(8): 510-514.

    [doi:10.1016/j.eimce.2025.05.009]

  • López-Olivencia M, de Pablo R, de Dios NP, García-Plaza S, Sáez-Noguero S, de la Fuente JS, Fortún J, Cuesta MCS.

    The adverse impact of cytomegalovirus infection on intensive care units outcomes in critically ill COVID-19 patients: a single-center prospective observational study.

    Infection . 53(5): 1801-1808.

    [doi:10.1007/s15010-025-02499-8]

  • Colomer Aguilar C, Negro-Vega E, Fernández de Gamarra-Martínez E, Martínez Castro B, Pérez Abánades M, Redondo Capafons S, Pérez Menéndez Conde C.

    [Translated article] Map of the residency rotations for hospital pharmacy residents in Spain.

    FARMACIA HOSPITALARIA . 49(5): .

    [doi:10.1016/j.farma.2025.06.010]

  • Hernández-García M, Nieto-Torres M, Guerra-Pinto N, Castillo-Polo JA, Saez de la Fuente J, Michelena M, Ponce-Alonso M, Soriano-Cuesta C, Díaz-Agero C, Cantón R, Coque TM, Ruiz-Garbajosa P.

    ICU environment as a reservoir of KPC-ST307-Klebsiella pneumoniae high-risk clone resistant to ceftazidime-avibactam.

    SCIENTIFIC REPORTS . 15(1): 29486-29486.

    [doi:10.1038/s41598-025-14987-w]

  • Esteban-Cartelle B, Anaya BJ, Pérez Menéndez-Conde C, Vicente-Oliveros N, Serrano DR, Álvarez-Díaz A, Fortún-Abete J, Martín-Dávila P.

    Stability of Ceftobiprole Medocaril in Portable Elastomeric Infusion Devices.

    Infectious diseases and therapy . 14(8): 1685-1696.

    [doi:10.1007/s40121-025-01174-7]

  • Máiz L, Nieto R, Durán D, Máiz J, Ruiz-Calvo G, Muriel A, Barbero E, Vélez-Díaz-Pallarés M, Morillo R.

    Short-term Tolerance to Inhaled Antibiotics in Patients With Bronchial Infection not Associated With Cystic Fibrosis.

    Open Respiratory Archives . 7(3): 100460-100460.

    [doi:10.1016/j.opresp.2025.100460]

  • Fortún J, Rodríguez-Gandía MA, Pintado V, Martín-Dávila P, García-González M, Graus J, Martín-Mateos R, Fuente JS, Muriel A, Moreno S.

    Oral nonabsorbable antibiotics for prevention of recurrent cholangitis; a brief report study.

    Infection . 53(3): 1219-1225.

    [doi:10.1007/s15010-025-02491-2]

  • Alonso-Gordoa T, Anguera G, Domínguez-Esteban M, Reig Ò, Martínez-Barros H, Molina-Cerrillo J, Cruz P, Maroto P.

    Expert consensus on patterns of progression in kidney cancer after adjuvant immunotherapy and subsequent treatment strategies.

    CANCER TREATMENT REVIEWS . 136: 102925-102925.

    [doi:10.1016/j.ctrv.2025.102925]

  • Rosas Cancio-Suárez M, Moreno A, del Campo Terrón S, Vivancos MJ, G García-Ruiz De Morales A, Martínez-Sanz J, Ron R, Sánchez-Izquierdo S, Vélez-Díaz-Pallarés M, Moreno S, Pérez-Elías MJ.

    Real-world efficacy and tolerability of CAB+RPV LA in women: addressing the gender gap in HIV treatment research.

    The Journal of antimicrobial chemotherapy . 80(4): 1084-1088.

    [doi:10.1093/jac/dkaf038]

  • Rodríguez Sagrado MA, Alvarez Criado J, Arenaza Peña AE, Escudero-Vilaplana V, Folguera Olias C, Herrero Fernandez M, Martinez Nieto C, Rubio Salvador AR, Sanmartin Fenollera P, Vazquez Castillo MJ.

    Niraparib Maintenance Therapy in Patients with Platinum-Sensitive Recurrent Ovarian Cancer: Real-World Experience at Hospitals in Spain.

    TARGETED ONCOLOGY . 20(2): 319-327.

    [doi:10.1007/s11523-024-01121-5]

  • Verdugo RM, Ferrán BB, Polo AF, Framiñan LM, Sesmero JMM, Velez-Diaz-Pallarés M, Vicente-Escrig E.

    [Translated article] Prioritisation of 2024-2027 initiatives of the strategic Map for outpatient pharmaceutical care of the Spanish Society of Hospital Pharmacy.

    FARMACIA HOSPITALARIA . 49(1): .

    [doi:10.1016/j.farma.2024.08.003]

  • Montero-Llorente B, Pérez Menéndez-Conde C, González Ferrer E, López Castellanos GT, Bedoya Del Olmo LM, Bermejo Vicedo T.

    Impact of pharmaceutical care on hospital readmissions for heart failure: a randomised trial.

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY . : .

    [doi:10.1136/ejhpharm-2024-004218]

  • Martínez-Barros H, Pousada-Fonseca Á, Pedreira-Bouzas J, Clopés-Estela A.

    Characteristics, clinical benefit and reimbursement of new authorisations for oncohaematology drugs in Spain between 2017 and 2020.

    FARMACIA HOSPITALARIA . 48(6): 272-277.

    [doi:10.1016/j.farma.2024.04.022]

  • Buti M, Calleja JL, Rodríguez MÁ, Domínguez-Hernández R, Cantero H, Espinoza-Cámac N, Casado MÁ.

    Clinical and economic value of bulevirtide in the treatment of chronic hepatitis D.

    GASTROENTEROLOGIA Y HEPATOLOGIA . : 502241-502241. Number of citations: 1

    [doi:10.1016/j.gastrohep.2024.502241]

  • PARRO MARTÍN, MARÍA DE LOS ÁNGELES.

    Guide for the efficient and safe delivery of Telepharmacy

    Health Policy and Technology . : .

    [doi:https://doi.org/10.1016/j.hlpt.2024.100899]